Patent 6 upheld in response to invalidation challenge Dublin, Ireland, 26 March 2024: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the China National Intellectual Property Administration (CNIPA) in.
Read Full ArticleSchedule time with ERS
‘If you’re using or plan to use CRISPR/Cas9
technology, you need a License
from ERS Genomics.’
Connect with us @ Bio Boston in June.
Getting a license is easy, fast & flexible.
Jon Kratochvil, Vice President, ERS Genonics.